All Articles

In February 2017, the FDA approved the oral drug Revlimid (lenalidomide) for maintenance (continuing) therapy for patients with multiple myeloma who had autologous hematopoietic stem-cell transplant. Revlimid was previously approved for multiple myeloma and for other types of cancer. Read More ›

In January 2017, the FDA approved Imbruvica (ibrutinib) for the treatment of patients with marginal zone lymphoma who need systemic therapy and have received at least 1 previous anti-CD20-based therapy. Read More ›

In February 2017, the FDA approved Opdivo (nivolumab), anti-PD-1 immunotherapy, for the treatment of patients with locally advanced or metastatic bladder cancer (urothelial carcinoma) whose disease progressed during or after platinum-containing chemotherapy, or within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy. Read More ›

In December 2016, the FDA approved Rubraca (rucaparib), a new oral PARP inhibitor, for the treatment of advanced ovarian cancer with a BRCA mutation (alteration) in patients who had received at least 2 chemotherapies. Read More ›

In February 2017, the FDA approved the oral drug Xermelo (telotristat ethyl) for the treatment of carcinoid syndrome diarrhea, in combination with a somatostatin analog (SSA), in adults with metastatic neuroendocrine tumors (NETs) whose condition is inadequately controlled by SSA therapy. Xermelo is the first oral therapy available for patients with carcinoid syndrome diarrhea in patients with NETs. Read More ›

March is multiple myeloma month. Check out our slideshow on this cancer type. Read More ›

Come learn more about 2016 Heroes of Hope and their cancer-related struggles and triumphs. Read More ›

The Leukemia & Lymphoma Society (LLS) provides support services for many patients with cancer, including education related to a variety of blood cancers, as well as financial support for patients with certain blood cancers to help them pay for their medications and other treatment-related expenses. CONQUER: the patient voice magazine asked Beatrice Abetti, LCSW, Director, Information Resource Center, LLS, to describe some of the patient support services provided by LLS, focusing on their financial assistance programs. Read More ›

CancerCare has been serving patients with cancer for more than 70 years. In this interview, Ms Levy discusses the patient support services provided by CancerCare, focusing on their financial assistance programs. Read More ›

Here are the highlights in this issue that we are confident you will value reading. Read More ›